GlassScriptPhysician profile
Erik R Lovria
NPI 1154526143
$3,000.84
in general payments reported to CMS, 2019-2025
15 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.13 · 2020: $852 · 2021: $257 · 2022: $63.99 · 2023: $378 · 2024: $1,220 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,114 · Travel and Lodging: $672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,114.27 |
| Travel and Lodging | $671.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $998.71 | 2020-2025 | |
| Zimmer Biomet Holdings, INC. | $774.82 | 2024 | Avenir |
| Stryker Corporation | $444.86 | 2019-2025 | Mako, Augment Injectable, Pangea |
| Medical Device Business Services, INC. | $188.09 | 2024 | Attune, Velys |
| Next Science LLC | $130.36 | 2021 | |
| Abbott Laboratories | $122.56 | 2023-2024 | Eterna, Proclaim |
| Heraeus Medical, LLC. | $75.56 | 2021 | |
| Bioventus LLC | $72.18 | 2022-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $63.68 | 2024 | Na |
| Smith+Nephew, INC. | $34.25 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Vertex Pharmaceuticals Incorporated | $29.08 | 2025 | |
| Heron Therapeutics, INC. | $21.28 | 2021 | |
| Ethicon US, LLC | $17.58 | 2021 | |
| Pacira Therapeutics, INC. | $15.15 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $12.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Lovria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.